Nanoparticles are tiny materials less than 1000 nm in size that have specific physicochemical properties different to bulk materials of the same composition and such properties make them very attractive for commercial and medical development. It is provide a promising for clinical translation to targeted drug delivery and treated different diseases with limited toxicity provide exciting research opportunities that demand multidisciplinary approaches. Therefore, there is a pressing need for careful consideration of benefits of the use of nanoparticles in medicine.

Mona Anwar, Forscherin für medizinische Biochemie, Abteilung für medizinische Biochemie, Nationales Forschungszentrum, Kairo, Ägypten.